Summary

New-onset diabetes after transplantation (NODAT) is recognized as one of the major medical complications of solid-organ transplantation. A spectrum of problems is attributed to NODAT, including impaired graft function, infectious complications, patient inconvenience, and increased costs, as well as patient mortality [Woodward RS et al. Am J Transplant 2003].